Literature DB >> 11931402

Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998.

N A Ansari1, A H Kombe, T A Kenyon, N M Hone, J W Tappero, S T Nyirenda, N J Binkin, S B Lucas.   

Abstract

BACKGROUND: Little is known about causes of death in countries of southern Africa seriously affected by the HIV/AIDS epidemic.
METHODS: After obtaining informed consent, autopsies were performed on 128 mainly hospitalised adults in Francistown, Botswana, between July 1997 and June 1998. Criteria for case selection included those who died before a diagnosis could be established, those whose condition deteriorated unexpectedly during hospitalization, and those who had respiratory disease. This represented 14% of adult medical patients who died in hospital during the study period.
RESULTS: Of the 128 patients, 104 (81%) were HIV-positive. Among HIV-positive patients, the most common pathologic findings were tuberculosis (TB) (40%), bacterial pneumonia (23%), Pneumocystis carinii pneumonia (11%), and Kaposi's sarcoma (11%); these conditions were the cause of death in 38%, 14%, 11%, and 6%, respectively. Of the 40 pulmonary TB cases, 90% also had disseminated extra-pulmonary TB. Chest radiology could not reliably distinguish the pathologies pre-mortem.
CONCLUSIONS: TB was the leading cause of death in our series of HIV-positive adults in Botswana, selected towards those with chest disease; in most, it was widely disseminated. Bacterial pneumonia also played an important role in mortality. Pneumocystis carinii pneumonia was present, but relatively uncommon.

Entities:  

Mesh:

Year:  2002        PMID: 11931402

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  83 in total

1.  Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control.

Authors:  Robin Wood; Keren Middelkoop; Landon Myer; Alison D Grant; Andrew Whitelaw; Stephen D Lawn; Gilla Kaplan; Robin Huebner; James McIntyre; Linda-Gail Bekker
Journal:  Am J Respir Crit Care Med       Date:  2006-09-14       Impact factor: 21.405

2.  Antigens of Mycobacterium tuberculosis recognized by antibodies during incipient, subclinical tuberculosis.

Authors:  Krishna K Singh; Yuxin Dong; John T Belisle; Jeffrey Harder; Vijay K Arora; Suman Laal
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

3.  Tuberculosis among Africans living in the United States, 2000-2009.

Authors:  Bisrat K Abraham; Carla A Winston; Elvin Magee; Roque Miramontes
Journal:  J Immigr Minor Health       Date:  2013-04

4.  Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?

Authors:  S D Lawn; A D Harries; B G Williams; R E Chaisson; E Losina; K M De Cock; R Wood
Journal:  Int J Tuberc Lung Dis       Date:  2011-05       Impact factor: 2.373

Review 5.  HIV and tuberculosis coinfection: inextricably linked liaison.

Authors:  Vincent Idemyor
Journal:  J Natl Med Assoc       Date:  2007-12       Impact factor: 1.798

6.  Hepatotoxicity During Isoniazid Preventive Therapy and Antiretroviral Therapy in People Living With HIV With Severe Immunosuppression: A Secondary Analysis of a Multi-Country Open-Label Randomized Controlled Clinical Trial.

Authors:  McNeil Ngongondo; Sachiko Miyahara; Michael D Hughes; Xin Sun; Gregory P Bisson; Amita Gupta; Johnstone Kumwenda; Jeffrey A Lavenberg; Thiago Silva Torres; Mulinda Nyirenda; Katende Kenneth Kidonge; Mina C Hosseinipour
Journal:  J Acquir Immune Defic Syndr       Date:  2018-05-01       Impact factor: 3.731

7.  Assessing the impact of prevalent tuberculosis on mortality among antiretroviral treatment initiators: accurate tuberculosis diagnosis is essential.

Authors:  Stephen D Lawn; Ankur Gupta; Robin Wood
Journal:  AIDS       Date:  2012-08-24       Impact factor: 4.177

8.  Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania.

Authors:  Humphrey J Shao; John A Crump; Habib O Ramadhani; Leonard O Uiso; Sendui Ole-Nguyaine; Andrew M Moon; Rehema A Kiwera; Christopher W Woods; John F Shao; John A Bartlett; Nathan M Thielman
Journal:  AIDS Res Hum Retroviruses       Date:  2009-12       Impact factor: 2.205

9.  Post-mortem histological pulmonary analysis in patients with HIV/AIDS.

Authors:  Alexandre de Matos Soeiro; André L D Hovnanian; Edwin Roger Parra; Mauro Canzian; Vera Luiza Capelozzi
Journal:  Clinics (Sao Paulo)       Date:  2008-08       Impact factor: 2.365

10.  Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis.

Authors:  Ferdinand M Mugusi; Saurabh Mehta; Eduardo Villamor; Willy Urassa; Elmar Saathoff; Ronald J Bosch; Wafaie W Fawzi
Journal:  BMC Public Health       Date:  2009-11-12       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.